Indian Sepsis Diagnostics Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period
With a population of 1.22 billion, today India is grappling with various health issues. One of them is management of illnesses like ‘Sepsis’, which is taking a toll not only in rural India but is also prominent in urban India. Sepsis is a life-threatening medical condition triggered due to the body’s response to an infection. It is often caused by microorganisms invading the body, either limited to a specific body part or can be widespread in the bloodstream. There are typically four progressive stages of Sepsis namely SIRS (Systematic Inflammatory Response Syndrome), SEPSIS, Septic Shock and MODS (Multiple Organ Dysfunction Syndrome). India currently tackles 750,000 cases of Sepsis every year of which overall mortality rate in ICU patients is 12.08% and in the severe stage Sepsis patients it is 59.26%. Factors such as rising number of affected population, strong presence of pipeline drugs, and technological advancement in sepsis assessment would drive the growth of sepsis and septic shock treatment market over the forecast period.
The major factors for the growth of the sepsis diagnostics market include the increasing burden of sepsis, the growing burden of hospital-acquired infections, the increasing number of pneumonia cases, the rise in the number of sepsis procedures, and an increase in funding for sepsis-related research activities. Hospital-acquired infections (HAIs) are the most common complications among hospitalized patients. The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness.